BINDEMITTEL

European patent · EP3668897 · In force

Register entry

Publication number
EP3668897
Application number
EP18759711
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 17, 2018
Published
Jun 24, 2020
Granted
Jun 5, 2024
Protection ends at the latest
Aug 16, 2038
Next annual fee due
Aug 31, 2027
IPC classes
C07K 16/28 (2006.01)
Priority
GB 201713298 18.08.2017
GB 201802595 16.02.2018
GB 201808570 24.05.2018
PCT application
PCT/GB2018/052347 17.08.2018
PCT publication
WO2019/034895 21.02.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Apr 16, 2025

    Change

    Published in Swissreg on 16.04.2025

  4. Sep 3, 2024

    Agent entered

    Representative
    M. ZARDI & CO. SA, Via Giovan Battista Pioda 6, 6900 Lugano

    Published in Swissreg on 03.09.2024

  5. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  6. Jun 5, 2024

    Granted

    Published in Swissreg on 05.06.2024

Parties

Holder

Centessa Pharmaceuticals (UK) Limited

3rd Floor 1 Ashley Road, Altrincham, Cheshire WA14 2DT, GB

Agent

M. ZARDI & CO SA

M. ZARDI & CO. SA

Via Giovan Battista Pioda 6, 6900 Lugano

Inventor

FINLAY, William, James, Jonathan

Sandwich Kent CT13 9FF, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.